Results 91 to 100 of about 630,776 (310)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

open access: yesMolecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen   +9 more
wiley   +1 more source

You Never Thought about Me, Did You?’ Cloning and the Right to Reproductive Choice in Eva Hoffman’s The Secret (2001)

open access: yesHumanities
This article will critically appraise the extent to which new developments in the fields of reproductive technology are shown to impact female bodily autonomy and reproductive choice in Eva Hoffman’s novel The Secret.
Laura-Jane Devanny
doaj   +1 more source

Ethics and cloning [PDF]

open access: yesBritish Medical Bulletin, 2018
Scientists have cloned animals since the late 19th century, but the crucial step for ethics was the cloning of the first mammal by somatic cell nuclear transfer in 1997. This suggested that scientists could also clone, and possibly enhance, human beings.This survey examines ethical literature on cloning since the 1960s.The one ethical area of agreement
openaire   +3 more sources

On cloning human beings

open access: yes, 2002
The purpose of this paper is to show that arguments for and against cloning fail to make their case because of one or both of the following reasons: 1) they take for granted customary beliefs and assumptions that are far from being unquestionable; 2 ...
de Melo-Martín, Inmaculada
core  

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma‐cfDNA of advanced breast cancer patients: A feasibility proof‐of‐concept study

open access: yesMolecular Oncology, EarlyView.
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou   +12 more
wiley   +1 more source

The Man-Simulacrum – the Human Future in Baudrillard’s Perspective

open access: yesПроблеми на постмодерността, 2017
The research studies Jean Baudrillard's conception about the merging of simulation and virtuality and its consequence on the notion and perception of man. It focuses on the duplicate-simulacrum of man that Baudrillard depicts in his works.
Gergana Popova
doaj  

HUMAN CLONING: PAPERS FROM A CHURCH CONSULTATION

open access: yes, 2001
Cloning : can it be good for us / Kevin Fitzgerald -- Table talk and public policy formation in the clone age / Margaret R. Mclean -- Broadening the church's conversation / Richard Perry -- Cloning : the destiny and dangers of being human / Philip ...
Evangelical Lutheran Church in America [ELCA]. Division for Church in Society   +1 more
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy